Potentiation of a homeopathic medicine – Thuja – using mid-infrared rays

Clinical dose reduction is achieved through potentiation, which is the process used to manufacture homeopathic medicine with varying potencies. In this study, we used 2–6 µm mid-infrared wavelength radiation to further amplify commercially available homeopathic medicines, such as thuja (Thuja occidentalis), a medication frequently used for a variety of ailments. We invented an emitter called MIRGA (mid-infrared generating atomizer) for potentiation purpose. The benefits of mid-IR potentiation include a reduction of the clinical dose, host stress, and resource and cost savings. The effects of irradiation on Thuja in chemical bond alterations and configurations are proven here by scientific instrumentations.